Artia Global Partners LP Q1 2025 Filing

Filed May 15, 2025

Portfolio Value

$395.1B

Holdings

32

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (32 positions)

#StockSharesValue% PortfolioType
1
LLYELI LILLY & CO
139,887$115.5B29.24%Put
2
SLNOSOLENO THERAPEUTICS INC
735,373$52.5B13.30%Put
3
VRNAVERONA PHARMA PLC
538,488$34.2B8.65%
4
ITCIEURINTRA-CELLULAR THERAPIES INC
219,719$29.0B7.34%
5
IM8NINSMED INC
318,239$24.3B6.14%
6
MRUSMERUS N V
424,640$17.9B4.52%
7
PTGXPROTAGONIST THERAPEUTICS INC
333,851$16.1B4.09%
8
ACLXARCELLX INC
229,085$15.0B3.80%
9
AZNASTRAZENECA PLC
190,752$14.0B3.55%
10
BSXBOSTON SCIENTIFIC CORP
129,700$13.1B3.31%
11
DGXQUEST DIAGNOSTICS INC
56,717$9.6B2.43%
12
ALNYALNYLAM PHARMACEUTICALS INC
28,600$7.7B1.95%
13
ARGXARGENX SE
11,311$6.7B1.69%
14
NUVLNUVALENT INC
90,745$6.4B1.63%
15
SRRKSCHOLAR ROCK HLDG CORP
172,185$5.5B1.40%
16
RVMDREVOLUTION MEDICINES INC
104,190$3.7B0.93%
17
RYTMRHYTHM PHARMACEUTICALS INC
50,000$2.6B0.67%
18
SWTXSPRINGWORKS THERAPEUTICS INC
53,930$2.4B0.60%
19
VKTXVIKING THERAPEUTICS INC
90,279$2.2B0.55%
20
VRDNVIRIDIAN THERAPEUTICS INC
160,000$2.2B0.55%
21
TGTXTG THERAPEUTICS INC
54,515$2.1B0.54%
22
ISRGINTUITIVE SURGICAL INC
3,500$1.7B0.44%
23
EYPTEYEPOINT PHARMACEUTICALS INC
316,700$1.7B0.43%
24
NBIXNEUROCRINE BIOSCIENCES INC
14,700$1.6B0.41%
25
UTHUNITED THERAPEUTICS CORP DEL
5,000$1.5B0.39%
26
XENEXENON PHARMACEUTICALS INC
40,000$1.3B0.34%
27
ASNDASCENDIS PHARMA A/S
7,440$1.2B0.29%
28
JANXJANUX THERAPEUTICS INC
38,100$1.0B0.26%
29
MREOMEREO BIOPHARMA GROUP PLC
421,359$948.1M0.24%
30
TVTXTRAVERE THERAPEUTICS INC
30,900$553.7M0.14%
31
CNTACENTESSA PHARMACEUTICALS PLC
35,226$506.6M0.13%
32
ORKAORUKA THERAPEUTICS INC
7,380$75.7M0.02%